{"id":"W2500482667","doi":"10.1182/blood-2016-02-699850","title":"Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":395,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Takeda Oncology","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Refractory (planetary science); Oncology; Lymphoma; Complete remission; Gastroenterology; Hodgkin lymphoma; Chemotherapy; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001953172,0.0003145213,0.0006022439,0.0002500847,0.0002302785,0.0006526617,0.0002130719,0.0004409143,0.0005151655],"category_scores_gemma":[0.00215131,0.0001058092,0.0008168046,0.0001696016,0.0002188735,0.0005175595,0.0002429161,0.0006983162,0.0001331661],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003455808,"about_ca_system_score_gemma":0.0002268417,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004905312,"about_ca_topic_score_gemma":0.0009254427,"domain_scores_codex":[0.9995918,0.0001927816,0.00004357657,0.00004699866,0.00004922257,0.00007566974],"domain_scores_gemma":[0.9984623,0.0004687106,0.0004563194,0.00009597429,0.00009724071,0.0004194252],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1917763,0.004884833,0.6188794,0.00046341,0.002279246,0.0009508833,0.0005532728,0.005244017,0.01433015,0.0002048074,0.002643862,0.1577898],"study_design_scores_gemma":[0.01315932,0.1661749,0.8034342,0.00009599546,0.002411023,0.001609863,0.0002639992,0.004379593,0.003825625,0.0002977108,0.00428231,0.00006548181],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964991,0.002514845,0.000134963,0.0001028159,0.00002411164,0.00001872591,0.0002042633,0.000007442126,0.0004937561],"genre_scores_gemma":[0.9986978,0.0003779689,0.0000678998,0.0001173672,0.00003844173,0.00001145357,0.0005093477,0.000001807168,0.0001778859],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001953172,"threshold_uncertainty_score":0.01032948,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009244482184418111,"score_gpt":0.2231038739298464,"score_spread":0.2138593917454283,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}